It was also possible that ESI-09 might exert its anti-cancer action through extramitochondrial deterioration since some mitochondrial uncouplers have been shown to inhibit several oncogenic pathways, such as Wnt/β-catenin, mTORC1, STAT3, and Notch [57,58]. This evidence concerns the gene STAT3 and cancer.